Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma.

Saved in:
Bibliographic Details
Title: Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma.
Authors: McManus HD; Department of Medicine, Duke University School of Medicine, Durham, NC. Electronic address: hannah.mcmanus@duke.edu., Long JB; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Westvold SJ; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Leapman MS; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Urology, Yale School of Medicine, New Haven, CT; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT., Hurwitz ME; Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Mitchell AP; Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Pollack CE; Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD and Johns Hopkins School of Nursing, Baltimore, MD., Gross CP; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT., Dinan MA; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.
Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2025 Jun; Vol. 23 (3), pp. 102330. Date of Electronic Publication: 2025 Mar 15.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1938-0682
DOI:10.1016/j.clgc.2025.102330